ArticleTherapeutic advances in neurological disorders2018

Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.

Benjamin Stolte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.